Events
UPCOMING SEMINARS
Competitive Landscape Seminar Series: Cardiovascular
June 22, 2012
Boston, MA
www.competitivelandscapeseries.com/cardiovascular/
This one-day seminar analyzes global cardiovascular treatment markets from both pharmaceutical and medical device perspectives.
Questions answered in this seminar include:
- Which companies dominate the cardiovascular market and how are their franchises expected to evolve out to 2018?
- What are the epidemiological trends in key cardiovascular/metabolic disorders between emerging and mature markets?
- What are the major areas of unmet need and what are the barriers to entry for emerging agents?
- Which online and offline sources do cardiologists use to make clinical decisions throughout the workday and at the point-of-care?
- What are the comparative economics of stroke prevention with pharmaceutical treatment vs. medical devices?
- How lucrative is the opportunity for renal denervation?
- What are the most promising targets and therapies in the dyslipidemia drug pipeline, and how do their development strategies compare?
Register today!
Competitive Landscape Seminar Series: Market Access
May 17, 2012
New York, NY
www.competitivelandscapeseries.com/market-access/
This exciting one-day seminar will feature comprehensive analysis of current and future trends in managed markets to help you understand and maximize opportunities. Expert analysts from Decision Resources Group will cover a range of industry issues, addressing the hottest topics in market access.
Register today!
WEBINARS
Recent Developments in Strategic Partnerships for Biosimilars – What is Important for a Successful Biosimilar Joint Venture?
As part of our Biosimilars Advisory Service, BioTrends Research Group is offering an exclusive webinar entitled Recent Developments in Strategic Partnerships for Biosimilars – What is Important for a Successful Biosimilar Joint Venture?
Date & Time
Recorded live on Friday, March 30, 2012
10 a.m. ET, 4 p.m. CET
Learn more!
ANALYST CALLS
Highlights from the 10th Annual EGA Biosimilars Symposium
As part of our Biosimilars Advisory Service, BioTrends Research Group is offering an exclusive analyst call entitled Highlights from the 10th Annual EGA Biosimilars Symposium.
Date & Time
Recorded live on Wednesday, May 9, 2012
10 a.m. ET, 4 p.m. CET
Learn more!
Implications of the FDA’s Draft Guidance for Biosimilars
As part of our Biosimilars Advisory Service, BioTrends Research Group is offering an exclusive analyst call entitled Implications of the FDA’s Draft Guidance for Biosimilars.
Date & Time
Recorded live on Monday, February 27, 2012
10 a.m. ET, 4 p.m. CET
Learn more!